Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 28903924.
- Also identified by DOI 10.1136/bmj.j3932 and PMC identifier 5596393.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Organisations such as the National Institute for Health and Care Excellence require the synthesis of evidence from existing studies to inform their decisions—for example, about the best available treatments with respect to multiple efficacy and safety outcomes. However, relevant studies may not provide direct evidence about all the treatments or outcomes of interest. Multivariate and network meta-analysis methods provide a framework to address this, using correlated or indirect evidence from such studies alongside any direct evidence. In this article, the authors describe the key concepts and assumptions of these methods, outline how correlated and indirect evidence arises, and illustrate the contribution of such evidence in real clinical examples involving multiple outcomes and multiple treatments
Medical subject headings
- Antineoplastic Agents, Hormonal
- Antineoplastic Agents, Hormonal/therapeutic use
- Cardiovascular Diseases
- Cardiovascular Diseases/blood
- Cardiovascular Diseases/epidemiology
- Clinical Trials as Topic
- Endometrial Neoplasms
- Endometrial Neoplasms/drug therapy
- Female
- Fibrinogen
- Fibrinogen/metabolism
- Humans
- Multivariate Analysis
- Myocardial Infarction
- Myocardial Infarction/drug therapy
- Network Meta-Analysis as Topic
- Progesterone
- Progesterone/therapeutic use
- Thrombolytic Therapy
- Treatment Outcome